$82.240
+2.155 (+2.62%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MIRM Prediction & Forecast by Similar Chart Analysis
Alphio's MIRM stock price prediction model matches the current Mirum Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $81.99 (-0.30%). The 1-week path is $81.55 (-0.84%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Mirum Pharmaceuticals Inc Stock?
Currently, Mirum Pharmaceuticals Inc is not a strong buy. The stock is priced at $80.14, which is significantly below the analyst price targets ranging from $130 to $200, indicating potential upside. However, the RSI is at 38.321, suggesting the stock is in a bearish trend, and the forward P/E ratio is extremely high at 166.67, indicating overvaluation concerns. The main risk is the recent negative net income of -790.15 million in Q1 2026, which raises concerns about the company's financial health.
MIRM stock price ended at $82.24 on Monday, after rising +2.62%
Mirum Pharmaceuticals Inc (MIRM) last closed at $82.24, gaining +2.62%. These facts feed the 1-day and 1-week MIRM price prediction above.
Forecast Drivers
Mirum Pharmaceuticals Inc (MIRM) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MIRM, ranked by similarity.
Seasonality analysis for MIRM
Historically the probability of a positive October return for MIRM is 100.00%. July offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MIRM
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $72.83 | $75.40 | $83.11 | -8.32% |
| Nov 2026 | $57.34 | $78.46 | $84.24 | -4.60% |
| Dec 2026 | $64.06 | $67.53 | $74.76 | -17.89% |
In 2026, Mirum Pharmaceuticals Inc (MIRM) is projected to range from $57.34 to $84.24.
Mirum Pharmaceuticals Inc 2026 monthly forecast
In Oct 2026, Mirum Pharmaceuticals Inc is projected to average $75.40, with a low of $72.83 and high of $83.11.
In Nov 2026, Mirum Pharmaceuticals Inc is projected to average $78.46, with a low of $57.34 and high of $84.24.
In Dec 2026, Mirum Pharmaceuticals Inc is projected to average $67.53, with a low of $64.06 and high of $74.76.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.